Insider filing · TWST
Emily M. Leproust
Chief Executive Officer
profile →
Twist Bioscience Corporation
TWST · Healthcare · 102 filings in 24 months
ticker →
Emily M. Leproust sold $6.3M of Twist Bioscience (TWST)
Executed Aug 25, disclosed Aug 27, 2 days later.
Value, as filed
$6.3M
41,570 sh across 5 lots
Executed
Aug 25
the trade date, as filed
Disclosed
Aug 27
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ELEmily M. Leproust (Chief Executive Officer) filed 20 Form 4 reports in the trailing twelve months (0 purchases, 20 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $56.3M of TWST (356,546 sh across 13 lots, as filed), executed Sep 17.
The name
TWSTHealthcare · Twist Bioscience Corporation manufactures and sells synthetic DNA-based products
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Emily M. Leproust in TWST
TWSTSALE
Twist Bioscience Corporation
$56.3M356,546 sh across 13 lots
Exec Sep 17
Filed Sep 21 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $923K
6,639 sh × $139.07
Exec Aug 21
Filed Aug 25 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $2.5M
19,952 sh × $125.08
Exec Aug 12
Filed Aug 14 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $14.2M
113,318 sh × $125.16
Exec Aug 10
Filed Aug 12 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $435K
5,101 sh × $85.32
Exec Aug 3
Filed Aug 5 · 4:05 PM ET TWSTSALE Twist Bioscience Corporation $1.8M
18,880 sh × $95.00
Exec Jun 25
Filed Jun 26 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation $147K
1,688 sh × $87.32
Exec Jun 22
Filed Jun 24 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation $158K
2,265 sh × $69.84
Exec Jun 8
Filed Jun 10 · 5:30 PM ET